Invivo Therapeutics Holdings Might Be Roaring In The Next Year
I regard Invivo Therapeutics Holdings Corp (NVIV.OB) as a good investment in a short time horizon
- (1888PressRelease) December 26, 2012 - Some of the key positive aspects of its business are in the following.
1. Market potential. Invivo was founded to develop a groundbreaking medical technology to treat Spinal Cord Injuries (SCI), for which there is no effective treatment but to ease the symptoms. Its indication can be extended to peripheral nerve injuries etc., so the potential of this market could easily hit $10 billion a year.
2. Product with clear safety and simple mechanism profile. A scaffold made of a biodegradable and biocompatible polymer -poly(glycerolco-sebacic acid), which is already approved by the FDA for surgical sutures. The creative part of this company is to apply the same material into the spinal cord to prevent "secondary injury" and promote neuroplasticity right after the initial SCI.
Therefore,
Complete Story »
Original Article: Invivo Therapeutics Holdings Might Be Roaring In The Next Year
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam